Amphotericin B deoxycholate: No significant advantage of a 24 h over a 6 h infusion schedule [6]

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 1, 2007, Pages 180-182

  Altmannsberger, Philipp ^a   Holler, Ernst ^a   Andreesen, Reinhard ^a   Krause, Stefan W ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Antifungals; Antimycotic; Continuous infusion; Empirical antifungal therapy; Nephrotoxicity

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; DIMETINDENE; MAGNESIUM; PARACETAMOL; PENTOXIFYLLINE; POTASSIUM;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER; CHILL; CONTINUOUS INFUSION; CONTROLLED STUDY; DEATH; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG ERUPTION; FEBRILE NEUTROPENIA; HUMAN; KIDNEY DISEASE; LETTER; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DEOXYCHOLIC ACID; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; HEMATOLOGIC DISEASES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; MIDDLE AGED; MYCOSES; TREATMENT OUTCOME;

EID: 34447535352     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm147     Document Type: Letter

References (5)

1. Peleg AY, Woods ML. Continuous and 4 h infusion of amphotericin B: A comparative study involving high-risk haematology patients. J Antimicrob Chemother 2004; 54: 803-8.
2. Eriksson U, Seifert B, Schaffner A. Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: Randomised controlled trial. BMJ 2001; 322: 579-82.
3. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14.
4. Maschmeyer G, Link H, Hiddemann W et al. Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer 1994; 73: 2296-304.
5. Girois SB, Chapuis F, Decullier E et al. Adverse effects of antifungal therapies in invasive fungal infections: Review meta-analysis. Eur J Clin Microbiol Infect Dis 2006; 25: 138-49.